Web Flow - Login to access your portal

PCI Builds North American Clinical Sales Team

PCI Clinical Services have expanded our North American Clinical sales team with the appointment of Nadine DuChateau as Business Development Executive.

Nadine-DuChateau

Following an extensive career in clinical development services with more than 15 years’ experience in the field, Nadine joins the PCI team to support the development of the company’s client base in the Midwest. Prior to PCI, Nadine spent two years at a leading contract development and manufacturing organization in the pharmaceutical and biotechnology sector.

At PCI, Nadine will be responsible for account management and territory growth for our global clinical packaging and logistics services in the Midwest, maintaining and growing market share with key customers while developing new business and cross-selling PCI’s high potency oral solid manufacturing, commercial packaging and analytical testing services.

Welcoming Nadine to PCI, Tim Roberts, PCI North America Business Development Director, commented: “We are thrilled Nadine will be part of our team. She brings a wealth of experience and has a glowing record of accomplishments that she’s achieved over her career. We are looking forward to working with her here at PCI Clinical Services and her insightful contributions to the success of our clients.

Nadine said: “I am excited for this new opportunity given PCI’s reputation as the market leader. I’m really looking forward to joining the team and leveraging my experience in my new role to deliver great results for both new and current clients.

Posted on Categories News

Leave a Reply

Your email address will not be published. Required fields are marked *

five × 1 =

Explore the PCI Process Phase by Phase

PRE-CLINICAL
PHASE I
PHASE II
PHASE III
COMMERCIAL

Swipe to explore the PCI Process

PRE CLINICAL

pre-clinical-icon
  • Formulation Development
  • Analytical development/characterisation

PHASE 1

PCI Phase 1
  • Formulation Development
  • Analytical Development
  • Drug in capsule/vial technology (Xcelodose)®
  • Phase I product manufacture
  • Tablets/Capsules
  • Blinding via over-encapsulation
  • Phase I packaging and labelling
  • Storage and distribution

PHASE 2

PCI Phase 2
  • Formulation Optimization
  • Dosage Form Process Validation
  • Analytical Testing and Stability Services
  • Phase II Product Manufacture
  • Tablets/Capsules
  • Blinding via over-encapsulation
  • Phase II packaging and labelling
  • Storage and distribution

PHASE 3

PCI Phase 3
  • Comparator Sourcing
  • Scale Up Studies
  • Phase III Product Manufacture
  • Tablets/Capsules
  • Blinding via over-encapsulation
  • Phase III packaging and labelling
  • Analytical testing and stability services
  • Storage and distribution

COMMERCIAL

PCI Commercial Phase
  • Scale up for commercial supply
  • Commercial product manufacture
  • Commercial packaging and labelling
  • Validation services
  • Analytical testing and stability services
  • Product release to market
  • Storage and distribution

PCI Points...

You told us what aspects you value as "very important" when choosing a vendor...

Why choose us...

Our global reach and localized support ensures PCI as a strategic partner remains focussed on delivering speed-to-market and the commercial success of our customers

PCI is a global company that focusses on delivering speed-to-market and the commercial success of our customers

Why choose us...